<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE COMBINED
FINANCIAL STATEMENTS OF GENZYME CORPORATION'S TISSUE REPAIR DIVISION FOR THE 
YEAR ENDED DECEMBER 31, 1995 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO 
SUCH FINANCIAL STATEMENTS
</LEGEND>
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
       
                             
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-START>                             JAN-01-1995
<PERIOD-END>                               DEC-31-1995
<EXCHANGE-RATE>                                      1
<CASH>                                          40,741
<SECURITIES>                                     6,832
<RECEIVABLES>                                    2,163
<ALLOWANCES>                                       325
<INVENTORY>                                        761
<CURRENT-ASSETS>                                50,358
<PP&E>                                           2,619
<DEPRECIATION>                                     657
<TOTAL-ASSETS>                                  52,649
<CURRENT-LIABILITIES>                            5,984
<BONDS>                                            169
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           121
<OTHER-SE>                                      45,805
<TOTAL-LIABILITY-AND-EQUITY>                    52,649
<SALES>                                          5,220
<TOTAL-REVENUES>                                 5,220
<CGS>                                            4,731
<TOTAL-COSTS>                                   28,448
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                   148
<INTEREST-EXPENSE>                                  40
<INCOME-PRETAX>                               (22,030)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (22,030)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (22,030)
<EPS-PRIMARY>                                   (2.28)
<EPS-DILUTED>                                     0.00